Collection of cervical secretions does not adversely affect Pap smears taken immediately afterwards

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 4, 1998, Pages 491-493

  Hildesheim, Allan ^a   Bratti, M Concepcion ^b   Edwards, Robert P ^c   Schiffman, Mark ^a   Rodriguez, Ana C ^b,d   Herrero, Rolando ^d,f   Alfaro, Mario ^b   Morera, Lidia A ^b   Ermatinger, Susan V ^e   Miller, Barbara T ^e   Crowley Nowick, Peggy A ^c,g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Social Security Administration   (Costa Rica)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d Ministry of Health   (Costa Rica)

^e JOHNS HOPKINS HOSPITAL   (United States)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTAMINATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SPONGE; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX MUCUS;

EID: 7344253052     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.4.491-493.1998     Document Type: Article

References (17)

1. Ashley, R. L., L. Corey, J. Dalessio, P. Wilson, M. Remington, G. Barnum, and P. Trethewey. 1994. Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections. J. Infect. Dis. 170:20-26.
2. Belec, L., D. Meillet, M. Levy, A. Georges, C. Tevi-Benissan, and J. Pillot. 1995. Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clin. Diagn. Lab. Immunol. 2:57-61.
3. Bouvet, J. P., L. Belec, R. Pires, and J. Pillot. 1994. Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination. Infect. Immun. 62:3957-3961.
4. Clerici, M., M. Merola, E. Ferrario, D. Trabattoni, M. L. Villa, B. Stefanon, D. J. Venzon, G. M. Shearer, G. DePalo, and E. Clerici. 1997. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J. Natl. Cancer Inst. 89:245-250.
5. Crowley-Nowick, P. A., M. C. Bell, R. Brockwell, R. P. Edwards, S. Chen, E. E. Partridge, and J. Mestecky. 1997. Rectal immunization for induction of specific antibody in the genital tract of women. J. Clin. Immunol. 17:370-379.
6. Haneberg, B., D. Kendall, H. M. Amerongen, F. M. Apter, J. P. Kraehenbuhl, and M. R. Neutra. 1994. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 62:15-23.
7. Herrero, R., M. H. Schiffman, C. Bratti, A. Hildesheim, I. Balmaceda, M. E. Sherman, M. Greenberg, F. Cardenas, V. Gomez, K. Helgesen, J. Morales, M. Hutchinson, L. Mango, M. Alfaro, N. W. Potischman, S. Wacholder, C. Swanson, and L. A. Brinton. 1997. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Pan Am. J. Public Health 1:362-374.
8. Hildesheim, A., M. H. Schiffman, T. Tsukui, C. A. Swanson. J. Lucci, D. R. Scott, P. Lawler, B. B. Rush, A. T. Lorincz, A. Corrigan, R. D. Burk, K. Helgesen, R. A. Houghten, J. A. Berzofsky, and T. R. Kramer. 1997. Immune activation in cervical neoplasia: cross-sectional association between plasma sIL-2R levels and disease. Cancer Epidemiol. Biomarkers Prevention 6:807-813.
9. Kurman, R. J., D. E. Henson, A. L. Herbst, K. L. Noller, and M. H. Schiffman. 1994. Interim guidelines tor management of abnormal cervical cytology. JAMA 271:1866-1869.
10. Kurman, R. J., and D. Solomon. 1994. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Springer-Verlag, New York, N.Y.
11. Kutteh, W. H., S. J. Prince, K. R. Hammond, C. C. Kutteh, and J. Mestecky. 1996. Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin. Exp. Immunol. 104: 538-542.
12. Quesnel, A., S. Cu-Uvin, D. Murphy, R. L. Ashley, T. Flanigan, and M. R. Neutra. 1997. Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women. J. Immunol. Methods 202:153-161.
13. Schiffman, M. Personal communication.
14. Schiller, J. T., and D. R. Lowy. 1996. Papillomavirus-like particles and HPV vaccine development. Semin. Cancer Biol. 7:373-382.
15. Tsukui, T., A. Hildesheim, M. H. Schiffman, J. Lucci, D. Contois, P. Lawler, B. B. Rush, A. T. Lorincz, A. Corrigan, D. P. Carbone, D. R. Scott, R. A. Houghten, and J. A. Berzofsky. 1996. IL-2 production by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res. 56:3967-3974.
16. Wang, Z., B. G. Hansson, O. Forslund, L. Dillner, M. Sapp, J. T. Schiller, B. Bjerre, and J. Dillner. 1996. Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA. J. Clin. Microbiol. 34:3056-3062.
17. Wu, T. C., and R. J. Kurman. 1997. Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms. J. Natl. Cancer Inst. 89: 185-187.